Ajay Gupta1, Kartik Kesavabhotla2, Hediyeh Baradaran2, Hooman Kamel2, Ankur Pandya2, Ashley E Giambrone2, Drew Wright2, Kevin J Pain2, Edward E Mtui2, Jasjit S Suri2, Pina C Sanelli2, Alvin I Mushlin2. 1. From the Department of Radiology (A.G., K.K., H.B., E.E.M., P.C.S.), Brain and Mind Research Institute (A.G., H.K.), Department of Neurology (H.K.), Department of Healthcare Policy and Research (A.P., A.E.G., P.C.S., A.I.M.), and Samuel J. Wood Library and C.V. Starr Biomedical Information Center (D.W., K.J.P.), Weill Cornell Medical College, New York, NY; and Stroke Screening and Monitoring Division, AtheroPoint LLC, Roseville, CA (J.S.S.). ajg9004@med.cornell.edu. 2. From the Department of Radiology (A.G., K.K., H.B., E.E.M., P.C.S.), Brain and Mind Research Institute (A.G., H.K.), Department of Neurology (H.K.), Department of Healthcare Policy and Research (A.P., A.E.G., P.C.S., A.I.M.), and Samuel J. Wood Library and C.V. Starr Biomedical Information Center (D.W., K.J.P.), Weill Cornell Medical College, New York, NY; and Stroke Screening and Monitoring Division, AtheroPoint LLC, Roseville, CA (J.S.S.).
Abstract
BACKGROUND AND PURPOSE: Ultrasonographic plaque echolucency has been studied as a stroke risk marker in carotid atherosclerotic disease. We performed a systematic review and meta-analysis to summarize the association between ultrasound-determined carotid plaque echolucency and future ipsilateral stroke risk. METHODS: We searched the medical literature for studies evaluating the association between carotid plaque echolucency and future stroke in asymptomatic patients. We included prospective observational studies with stroke outcome ascertainment after baseline carotid plaque echolucency assessment. We performed a meta-analysis and assessed study heterogeneity and publication bias. We also performed subgroup analyses limited to patients with stenosis ≥50%, studies in which plaque echolucency was determined via subjective visual interpretation, studies with a relatively lower risk of bias, and studies published after the year 2000. RESULTS: We analyzed data from 7 studies on 7557 subjects with a mean follow-up of 37.2 months. We found a significant positive relationship between predominantly echolucent (compared with predominantly echogenic) plaques and the risk of future ipsilateral stroke across all stenosis severities (0% to 99%; relative risk, 2.31; 95% confidence interval, 1.58-3.39; P<0.001) and in subjects with ≥50% stenosis (relative risk, 2.61; 95% confidence interval, 1.47-4.63; P=0.001). A statistically significant increased relative risk for future stroke was preserved in all additional subgroup analyses. No statistically significant heterogeneity or publication bias was present in any of the meta-analyses. CONCLUSIONS: The presence of ultrasound-determined carotid plaque echolucency provides predictive information in asymptomatic carotid artery stenosis beyond luminal stenosis. However, the magnitude of the increased risk is not sufficient on its own to iden tify patients likely to benefit from surgical revascularization.
BACKGROUND AND PURPOSE: Ultrasonographic plaque echolucency has been studied as a stroke risk marker in carotid atherosclerotic disease. We performed a systematic review and meta-analysis to summarize the association between ultrasound-determined carotid plaque echolucency and future ipsilateral stroke risk. METHODS: We searched the medical literature for studies evaluating the association between carotid plaque echolucency and future stroke in asymptomatic patients. We included prospective observational studies with stroke outcome ascertainment after baseline carotid plaque echolucency assessment. We performed a meta-analysis and assessed study heterogeneity and publication bias. We also performed subgroup analyses limited to patients with stenosis ≥50%, studies in which plaque echolucency was determined via subjective visual interpretation, studies with a relatively lower risk of bias, and studies published after the year 2000. RESULTS: We analyzed data from 7 studies on 7557 subjects with a mean follow-up of 37.2 months. We found a significant positive relationship between predominantly echolucent (compared with predominantly echogenic) plaques and the risk of future ipsilateral stroke across all stenosis severities (0% to 99%; relative risk, 2.31; 95% confidence interval, 1.58-3.39; P<0.001) and in subjects with ≥50% stenosis (relative risk, 2.61; 95% confidence interval, 1.47-4.63; P=0.001). A statistically significant increased relative risk for future stroke was preserved in all additional subgroup analyses. No statistically significant heterogeneity or publication bias was present in any of the meta-analyses. CONCLUSIONS: The presence of ultrasound-determined carotid plaque echolucency provides predictive information in asymptomatic carotid artery stenosis beyond luminal stenosis. However, the magnitude of the increased risk is not sufficient on its own to iden tify patients likely to benefit from surgical revascularization.
Authors: Andrew N Nicolaides; Stavros K Kakkos; Efthyvoulos Kyriacou; Maura Griffin; Michael Sabetai; Dafydd J Thomas; Thomas Tegos; George Geroulakos; Nicos Labropoulos; Caroline J Doré; Tim P Morris; Ross Naylor; Anne L Abbott Journal: J Vasc Surg Date: 2010-12 Impact factor: 4.268
Authors: Andrew N Nicolaides; Stavros K Kakkos; Maura Griffin; Michael Sabetai; Surinder Dhanjil; Daffyd J Thomas; George Geroulakos; Niki Georgiou; Susan Francis; Elena Ioannidou; Caroline J Doré Journal: Vascular Date: 2005 Jul-Aug Impact factor: 1.285
Authors: J F Polak; L Shemanski; D H O'Leary; D Lefkowitz; T R Price; P J Savage; W E Brant; C Reid Journal: Radiology Date: 1998-09 Impact factor: 11.105
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: PLoS Med Date: 2009-07-21 Impact factor: 11.069
Authors: Stavros K Kakkos; Maura B Griffin; Andrew N Nicolaides; Efthyvoulos Kyriacou; Michael M Sabetai; Thomas Tegos; Gregory C Makris; Dafydd J Thomas; George Geroulakos Journal: J Vasc Surg Date: 2013-01-18 Impact factor: 4.268
Authors: Gowri Raman; Denish Moorthy; Nira Hadar; Issa J Dahabreh; Thomas F O'Donnell; David E Thaler; Edward Feldmann; Joseph Lau; Georgios D Kitsios Journal: Ann Intern Med Date: 2013-05-07 Impact factor: 25.391
Authors: Luca Saba; Pankaj K Jain; Harman S Suri; Nobutaka Ikeda; Tadashi Araki; Bikesh K Singh; Andrew Nicolaides; Shoaib Shafique; Ajay Gupta; John R Laird; Jasjit S Suri Journal: J Med Syst Date: 2017-05-13 Impact factor: 4.460
Authors: P Krishna Kumar; Tadashi Araki; Jeny Rajan; Luca Saba; Francesco Lavra; Nobutaka Ikeda; Aditya M Sharma; Shoaib Shafique; Andrew Nicolaides; John R Laird; Ajay Gupta; Jasjit S Suri Journal: Med Biol Eng Comput Date: 2016-12-10 Impact factor: 2.602
Authors: Amir A Khan; Siddhartha Sikdar; Thomas Hatsukami; Juan Cebral; Michael Jones; John Huston; George Howard; Brajesh K Lal Journal: J Vasc Surg Date: 2017-03-06 Impact factor: 4.268
Authors: Ankush Jamthikar; Deep Gupta; Narendra N Khanna; Tadashi Araki; Luca Saba; Andrew Nicolaides; Aditya Sharma; Tomaz Omerzu; Harman S Suri; Ajay Gupta; Sophie Mavrogeni; Monika Turk; John R Laird; Athanasios Protogerou; Petros P Sfikakis; George D Kitas; Vijay Viswanathan; Gyan Pareek; Martin Miner; Jasjit S Suri Journal: Curr Atheroscler Rep Date: 2019-05-01 Impact factor: 5.113
Authors: Dixon Yang; Sunil Iyer; Hannah Gardener; David Della-Morte; Milita Crisby; Chuanhui Dong; Ken Cheung; Consuelo Mora-McLaughlin; Clinton B Wright; Mitchell S Elkind; Ralph L Sacco; Tatjana Rundek Journal: Cerebrovasc Dis Date: 2015-07-25 Impact factor: 2.762
Authors: Narendra N Khanna; Ankush D Jamthikar; Deep Gupta; Matteo Piga; Luca Saba; Carlo Carcassi; Argiris A Giannopoulos; Andrew Nicolaides; John R Laird; Harman S Suri; Sophie Mavrogeni; A D Protogerou; Petros Sfikakis; George D Kitas; Jasjit S Suri Journal: Curr Atheroscler Rep Date: 2019-01-25 Impact factor: 5.113